Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares US Real Estate ETF
IYR
|
+$1.12B |
| 2 |
Amazon
AMZN
|
+$606M |
| 3 |
State Street Consumer Staples Select Sector SPDR ETF
XLP
|
+$542M |
| 4 |
Invesco QQQ Trust
QQQ
|
+$409M |
| 5 |
Apple
AAPL
|
+$302M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Visa
V
|
+$2.23B |
| 2 |
iShares Russell 2000 ETF
IWM
|
+$1.41B |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.26B |
| 4 |
iShares MSCI ACWI ETF
ACWI
|
+$935M |
| 5 |
DuPont de Nemours
DD
|
+$669M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 9.63% |
| 2 | Financials | 5.94% |
| 3 | Consumer Discretionary | 5% |
| 4 | Communication Services | 4.96% |
| 5 | Healthcare | 4.23% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3226
Fossil Group
FOSL
$293M
| $470K | ﹤0.01% |
54,014
-5,538
| -9% | -$46.6K |
|
3227
CALL
Hecla Mining
HL
$9.47B
| $470K | ﹤0.01% |
72,600
| – | – |
|
3228
Future Fuel
FF
$217M
| $469K | ﹤0.01% |
36,961
+5,533
| +18% | +$66.8K |
|
|
OLP
3229
One Liberty Properties
OLP
$530M
| $469K | ﹤0.01% |
23,315
-4,170
| -15% | -$74.7K |
|
|
CUTR
3230
DELISTED
Cutera, Inc.
CUTR
| $469K | ﹤0.01% |
19,428
-1,804
| -8% | -$38.6K |
|
|
UBA
3231
DELISTED
Urstadt Biddle Properties Inc. Class A
UBA
| $469K | ﹤0.01% |
+33,156
| New | +$395K |
|
3232
Alkermes
ALKS
$8.22B
| $468K | ﹤0.01% |
23,503
-4,653
| -17% | -$85.2K |
|
3233
Central Garden & Pet Co
CENT
$2.69B
| $468K | ﹤0.01% |
15,109
+376
| +3% | +$12K |
|
3234
KraneShares CSI China Internet ETF
KWEB
$5.64B
| $467K | ﹤0.01% |
6,091
-12,256
| -67% | -$908K |
|
3235
RPC Inc
RES
$1.24B
| $466K | ﹤0.01% |
147,955
-152
| -0.1% | -$457 |
|
3236
iShares MSCI Turkey ETF
TUR
$200M
| $466K | ﹤0.01% |
17,617
-8,097
| -31% | -$177K |
|
3237
Biglari Holdings Class B
BH
$1.25B
| $465K | ﹤0.01% |
4,182
-552
| -12% | -$56.7K |
|
3238
Phibro Animal Health
PAHC
$1.47B
| $465K | ﹤0.01% |
23,976
-750
| -3% | -$13.8K |
|
3239
Huntsman Corp
HUN
$1.71B
| $464K | ﹤0.01% |
18,465
-40,004
| -68% | -$993K |
|
3240
Ocular Therapeutix
OCUL
$1.79B
| $464K | ﹤0.01% |
22,428
-8,019
| -26% | -$119K |
|
3241
Theravance Biopharma
TBPH
$874M
| $464K | ﹤0.01% |
26,104
-17,016
| -39% | -$305K |
|
|
CERN
3242
CALL
DELISTED
Cerner Corp
CERN
| $463K | ﹤0.01% |
5,900
-225,000
| -97% | -$16.7M |
|
3243
Elbit Systems
ESLT
$37.9B
| $462K | ﹤0.01% |
3,531
+748
| +27% | +$90.1K |
|
3244
iShares MSCI Canada ETF
EWC
$6.13B
| $462K | ﹤0.01% |
15,005
-239,381
| -94% | -$7.02M |
|
3245
PUT
STMicroelectronics
STM
$46.7B
| $460K | ﹤0.01% |
12,400
| – | – |
|
|
ISEE
3246
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
| $460K | ﹤0.01% |
66,556
+29,785
| +81% | +$191K |
|
3247
Akebia Therapeutics
AKBA
$354M
| $458K | ﹤0.01% |
163,792
-20,701
| -11% | -$60.4K |
|
|
FITB
3248
CALL
Fifth Third Bancorp
FITB
$51.2B
| $458K | ﹤0.01% |
16,600
-1,500
| -8% | -$37.9K |
|
3249
MacroGenics
MGNX
$235M
| $458K | ﹤0.01% |
20,011
-6,631
| -25% | -$153K |
|
3250
Schneider National
SNDR
$6.26B
| $458K | ﹤0.01% |
22,137
-1,737
| -7% | -$38.8K |
|
Similar funds
Barclays's Q4 2020 Portfolio in Review
As of Q4 2020, Barclays held 5,338 positions worth $189B, up 12% from $168B the previous quarter. Its ten largest holdings account for 35% of the portfolio.
Barclays's Q4 2020 filing shows 130 new, 1,373 increased, 2,436 reduced and 454 closed positions. Its largest new stake was FTAI Aviation: 2,107,800 shares worth $42.2M. The largest sale was Visa, an estimated $2.23B.
By sector, the portfolio is most concentrated in Technology at 9.6% of assets, up from 8.9% a quarter earlier, followed by Financials and Consumer Discretionary.
- Barclays's largest Q4 2020 buy was FTAI Aviation: 2,107,800 shares worth $42.2M.
- Barclays added most to iShares US Real Estate ETF in Q4 2020, an estimated $1.12B increase.
- Barclays's biggest Q4 2020 reduction was Visa, cutting an estimated $2.23B.
- Barclays fully exited Noble Energy, Inc. in Q4 2020, selling an estimated $167M.
- Barclays's ten largest holdings make up 35% of its $189B portfolio in Q4 2020.
- Barclays opened 130 new positions and closed 454 in Q4 2020.
- Barclays's portfolio value rose 12% quarter-over-quarter to $189B.
Based on Barclays's 13F filing for Q4 2020, filed 11 Feb 2021.